B-M/McNeil suit
Executive Summary
A federal judge has denied McNeil's motion to set aside an earlier court decision in favor of Bristol-Myers. McNeil had challenged Bristol-Myers' advertising claim that two tablets of its Nuprin OTC ibuprofen product were superior to two tablets of McNeil's Extra-Strength Tylenol brand acetaminophen product ("The Pink Sheet" Sept. 15, T&G-1).
A federal judge has denied McNeil's motion to set aside an earlier
court decision in favor of Bristol-Myers. McNeil had challenged
Bristol-Myers' advertising claim that two tablets of its
Nuprin OTC ibuprofen product were superior to two tablets of
McNeil's Extra-Strength Tylenol brand acetaminophen product
("The Pink Sheet" Sept. 15, T&G-1). |